Tarceva for liver cancer
by
Mark LevinPosted
Wed 01 Jul 2009 6:35pmTarceva is targeted anticancer drug that works by blocking a biological pathway referred to as the epidermal growth factor receptor (EGFR) pathway. The EGFR pathway is involved in cell growth and replication and when mutated or altered, excessive replication of cells can occur. Tarceva has been shown to improve treatment outcomes in selected
Read on »
Tarceva for head and neck cancer
by
Mark LevinPosted
Wed 25 Nov 2009 10:03pmTarceva is currently FDA approved for pancreatic cancer in combination with gemcitabine and for non-small cell lung cancer for second line. There are ongogn trials in head and neck cancer, for example, Study of RADPLAT and Tarceva in Locally Advanced Head and Neck Squamous Cell Carcinoma (SCCA), NCT00304278. The purpose of this study is to determine
Read on »
Tarceva, Iressa and EGFR screening.
by
Dr. Steve MurphyPosted
Thu 20 Aug 2009 10:21pm
No Duh.
Can't believe I missed this yesterday.In the NEJM there is an article talking about Tarceva therapy (Very Expensive) and that it targets lung cancers that have EGFR mutations. So if you don't have those mutations, why would we expect you to benefit from these expensive drugs first line?
Wha?
Ok let me explain.
Read this first
Read on »
Tarceva for biliary cancer
by
Mark LevinPosted
Tue 11 May 2010 5:55pm
Erlotinib has shown activity individually, as single drugs, or in combination with chemotherapy in upper gastro-intestinal cancers, including esophageal and gastro-esophageal adenocarcinomas, gastric cancer and pancreatic cancer. In a recent study, forty-two patients with biliary cancer were enrolled. Seven of the patients (17%; 95% CI, 7% ...
Read on »
Two drugs don't boost lung cance...
by
Dr. Rubens D.Posted
Tue 07 Oct 2008 7:16pm
into the benefits of combining their Tarceva and Avastin drugs for lung cancer patients did not show an increase in overall survival.
Both drugs are targeted therapies -- modern medicines... and Genentech said on Monday a Phase III study investigated the addition of Avastin to Tarceva compared with Tarceva alone for the treatment of patients with advanced non-small cell lung
Read on »
Sutent for lung cancer
by
Mark LevinPosted
Wed 24 Nov 2010 5:05pm
, in August 2010, Pfizer halted a study with Sutent. The trial looked at Sutent as an add-on therapy to Roche's Tarceva, comparing the two-drug regimen with Tarceva alone. The combo didn't extend patients' lives any longer than Tarceva did by itself.
Read on »
Drugs for Skin Cancers
by
Docs OrdersPosted
Sun 24 Aug 2008 4:41pm
Here is a list of drugs and medications that are commonly prescribed to treat Skin Cancers:
Avobenzone
Imiquimod
Tamoxifen
Tarceva
Tretinoin
These are just some of the drugs and medications that are often used to treat Skin Cancers.If you're interested in finding more information, tips, news and videos about Skin Cancers, go to the Skin Cancers
Read on »
Drugs for Cervical Cancer
by
Med TeamPosted
Sun 24 Aug 2008 4:41pm
Here is a list of drugs and medications that are commonly prescribed to treat Cervical Cancer:
Diethylstilbestrol
Herceptin
Hycamtin
Tamoxifen
Tarceva
These are just some of the drugs and medications that are often used to treat Cervical Cancer.If you're interested in finding more information, tips, news and videos about Cervical Cancer
Read on »
Drugs for Liver Cancer
by
Disease FighterPosted
Sun 24 Aug 2008 4:41pm
Here is a list of drugs and medications that are commonly prescribed to treat Liver Cancer:
5-fu
Aldactone
Ambien
Avastin
Capecitabine
Chemotherapy
Irinotecan
Lasix
Liver transplant
Nexavar
Oxaliplatin
Pain medications
Tarceva
These are just some of the drugs and medications that are often used to treat Liver Cancer.If
Read on »
Progress in fighting lung cancer ...
by
Dr. Rubens D.Posted
Sun 31 May 2009 10:40pm1 Comment
the combination of two anti-cancer treatments following standard chemotherapy can slow the advance of lung cancer.
Patients treated with a combination of Tarceva, sold by the Swiss... to receive Avastin and a placebo, or Avastin and Tarceva. Those in the Tarceva group survived an average of 4.8 months before the cancer started growing again, compared to 3.7 months
Read on »